APA

Vrana J. A., Bieszczad C. K., Cleaveland E. S., Ma Y., Park J. P., Mohandas T. K. & Craig R. W. (20020305). An MCL1-overexpressing Burkitt lymphoma subline exhibits enhanced survival on exposure to serum deprivation, topoisomerase inhibitors, or staurosporine but remains sensitive to 1-beta-D-arabinofuranosylcytosine. : Cancer research.

Chicago

Vrana Julie A, Bieszczad Christine K, Cleaveland Emily S, Ma Yan, Park Jonathan P, Mohandas Thuluvancheri K and Craig Ruth W. 20020305. An MCL1-overexpressing Burkitt lymphoma subline exhibits enhanced survival on exposure to serum deprivation, topoisomerase inhibitors, or staurosporine but remains sensitive to 1-beta-D-arabinofuranosylcytosine. : Cancer research.

Harvard

Vrana J. A., Bieszczad C. K., Cleaveland E. S., Ma Y., Park J. P., Mohandas T. K. and Craig R. W. (20020305). An MCL1-overexpressing Burkitt lymphoma subline exhibits enhanced survival on exposure to serum deprivation, topoisomerase inhibitors, or staurosporine but remains sensitive to 1-beta-D-arabinofuranosylcytosine. : Cancer research.

MLA

Vrana Julie A, Bieszczad Christine K, Cleaveland Emily S, Ma Yan, Park Jonathan P, Mohandas Thuluvancheri K and Craig Ruth W. An MCL1-overexpressing Burkitt lymphoma subline exhibits enhanced survival on exposure to serum deprivation, topoisomerase inhibitors, or staurosporine but remains sensitive to 1-beta-D-arabinofuranosylcytosine. : Cancer research. 20020305.